33
Participants
Start Date
October 31, 2006
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Sunitinib Malate
Once daily oral doses on days 1-28 of each 42-day cycle. The dose for the first 2 cycles will be 37.5 mg daily for 28 days, every 42 days. Dose may be escalated to 50 mg daily for 28 days at the treating investigator's discretion.
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Collaborators (1)
Pfizer
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER